Homo sapiens Protein: WNK2 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-76534.5 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | WNK2 | ||||||||||||||||||
Protein Name | WNK lysine deficient protein kinase 2 | ||||||||||||||||||
Synonyms | |||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000297954 | ||||||||||||||||||
InnateDB Gene | IDBG-76524 (WNK2) | ||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Serine/threonine kinase which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation. Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively. Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5. Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression. Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1. WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity. {ECO:0000269PubMed:17667937, ECO:0000269PubMed:18593598, ECO:0000269PubMed:21733846}. | ||||||||||||||||||
Subcellular Localization | Cytoplasm. Cell membrane. | ||||||||||||||||||
Disease Associations | |||||||||||||||||||
Tissue Specificity | Expressed in various cancer cell lines (at protein level). Predominantly expressed in heart, brain, skeletal muscle and colon. {ECO:0000269PubMed:11571656, ECO:0000269PubMed:17667937, ECO:0000269PubMed:21733846}. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 8 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR000719
Protein kinase domain IPR001245 Serine-threonine/tyrosine-protein kinase catalytic domain IPR002290 Serine/threonine/dual specificity protein kinase, catalytic domain IPR011009 Protein kinase-like domain IPR020635 Tyrosine-protein kinase, catalytic domain IPR024678 Serine/threonine-protein kinase OSR1/WNK, CCT domain |
||||||||||||||||||
PFAM |
PF00069
PF07714 PF12202 |
||||||||||||||||||
PRINTS |
PR00109
|
||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00220
SM00219 |
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | Q9Y3S1 | ||||||||||||||||||
PhosphoSite | PhosphoSite-Q9Y3S1 | ||||||||||||||||||
TrEMBL | |||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 65268 | ||||||||||||||||||
UniGene | Hs.654856 | ||||||||||||||||||
RefSeq | NP_001269323 | ||||||||||||||||||
HUGO | HGNC:14542 | ||||||||||||||||||
OMIM | 606249 | ||||||||||||||||||
CCDS | CCDS75858 | ||||||||||||||||||
HPRD | 06951 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AB044546 AB051547 AJ242724 AL354991 AL390760 AL583839 BC037965 | ||||||||||||||||||
GenPept | AAH37965 BAB18648 BAB21851 CAB44308 CAH73069 CAH73070 CAI12344 CAI12345 CAI14449 CAI14450 | ||||||||||||||||||